Celgene beats Street

Celgene (NASDAQ:CELG) reported 2Q08 non-GAAP diluted EPS of $0.37, beating by $0.02 the Street's estimate of $0.35 and up from $0.17 in 2Q07. Second quarter non-GAAP revenue increased 63% to $566.6 mi...